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Contagious agalactia is a mycoplasmal disease of sheep and goats that can cause 
serious economic losses from mastitis, polyarthritis and keratoconjunctivitis. In lambs 
and kids, losses due to septicemia and pneumonia can be high. Some outbreaks may 
affect most of the animals on a farm. Although contagious agalactia has been eradicated 
from some countries, it may be difficult to control where it is widespread. Antibiotics 
can result in symptomatic improvement, but treated animals may remain carriers. 
Etiology 
Contagious agalactia is classically caused by infection with Mycoplasma 
agalactiae. M. capricolum subsp. capricolum, M. putrefaciens, M. mycoides subsp. 
capri or M. mycoides subsp. mycoides large colony (LC) type can also cause this 
disease. (Note: Some genetic evidence suggests that M. mycoides capri and M. 
mycoides mycoides LC may be the same organism, and they may be combined into a 
single taxon in the future.) Whether M. putrefaciens alone causes contagious agalactia 
in healthy animals, or whether it is pathogenic only when combined with other 
diseases or environmental stressors is uncertain.  
Species Affected 
Contagious agalactia primarily affects sheep and goats. Although M. agalactiae 
causes disease in both species, M. capricolum capricolum, M. mycoides capri and M. 
mycoides mycoides LC primarily affect goats and are rarely found in sheep. M. 
putrefaciens has, to date, been reported only in goats. 
Other species may also be infected with these organisms. M. agalactiae has been 
isolated from Spanish ibexes (Capra pyrenaica), and antibodies to this organism have 
been reported in roe deer (Capreolus capreolus) and red deer (Cervus elaphus). 
Antibodies to M. mycoides mycoides LC and M. capricolum capricolum have been 
found in South American camelids. M. capricolum capricolum and a unique 
mycoplasmal strain that was closely related to M. mycoides mycoides LC were 
reported from captive Vaal rhebok (Pelea capreolus) from South Africa, and were 
implicated in a fatal systemic illness. M. mycoides mycoides LC has also been 
reported in cattle. 
Geographic Distribution 
Contagious agalactia has been reported in much of the world. This disease is 
particularly common in the Mediterranean region of Europe, Asia and North Africa. 
The distribution of the causative agents can vary.  
Three isolations of M. agalactiae have been reported from the United States, but 
these North American strains did not seem to cause significant disease. M. 
putrefaciens was isolated from goats in California in 1979, and caused a large 
outbreak in that state in 1987.  
Transmission 
Infected animals shed organisms in urine, feces, nasal and ocular discharges, and 
secretions including milk. Mycoplasma spp. can be shed during more than one 
lactation; between lactations, the organisms can survive in the supramammary lymph 
nodes. Carriers can remain infectious for months, and in some cases, for more than a 
year. Animals become infected by ingestion or occasionally by inhalation, as well as 
through the teat openings. Young animals are usually infected when they drink 
contaminated milk or colostrum from the dam. Animals may also ingest mycoplasmas 
shed in other secretions and excretions, either directly or in feed or water. Organisms 
can enter the teat opening directly during milking, or from fomites such as bedding. 
Aerosol transmission is possible over short distances.  
The organisms that cause contagious agalactia can be transmitted on fomites. 
Although mycoplasmas are relatively fragile in the environment, most of the 
organisms that cause this disease can produce biofilms, which protect them from heat 
and drying, and enhance their survival. In one study, biofilm production was  
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particularly abundant for M. putrefaciens and M. 
agalactiae, while M. capricolum capricolum was unable to 
produce a significant biofilm. Survival appears to be 
particularly likely if the temperature is low.  
Incubation Period 
The incubation period is one to eight weeks. 
Clinical Signs 
Generally, the clinical signs are more severe in goats. 
Infections with M. agalactiae may be asymptomatic, acute 
or chronic. Acute cases begin with a transient fever 
followed by malaise, inappetence and mastitis. The udder is 
hot and swollen, and the milk is usually greenish–yellow or 
grayish–blue, with a consistency that is watery at first then 
becomes lumpy. Lactation diminishes and may completely 
stop. Eventually, the udder atrophies and becomes fibrosed. 
Polyarthritis is also common, especially in the tarsal and 
carpal joints, and may be the major clinical sign in male 
goats. The severity of the arthritis varies; some animals are 
merely stiff while others become severely lame and may be 
unable to stand or walk. Keratoconjunctivitis develops in 
approximately half of all infections. It is usually transient, 
but occasionally becomes chronic, and can cause blindness 
in one or both eyes. Pneumonia is not consistently seen 
with M. agalactiae, but organisms are occasionally isolated 
from lesions in the lungs. Abortions can occur in 
chronically infected animals.. Granular vulvovaginitis has 
also been reported in goats.  
M. mycoides mycoides LC, M. mycoides capri, M. 
capricolum capricolum and M putrefaciens cause similar 
clinical signs, but are reported mainly in goats. Most 
infections with these organisms are acute or hyperacute. 
Some infected goats, especially nursing kids, develop 
pneumonia and/or septicemia with fever, prostration, 
anorexia and generalized malaise. The mortality rate in 
these animals may be high, and other clinical signs may not 
be seen. Sudden death has also been reported in some 
infected herds. Other goats develop mastitis, arthritis and 
keratoconjunctivitis, although ocular signs have not yet 
been documented with M. putrefaciens. Pregnant animals 
may abort. M. putrefaciens has been linked to genital 
lesions in both sexes.  
Infections with M. mycoides mycoides LC and M. 
capricolum capricolum are reported infrequently in sheep. 
M. mycoides mycoides LC has been found in sheep with 
vulvovaginitis and balanoposthitis. M. capricolum 
capricolum has also been linked to genital lesions. M. 
putrefaciens has been not documented in this species.  
Post Mortem Lesions 
At necropsy, the lesions may include signs of 
septicemia, pneumonia, mastitis, arthritis and/or ocular 
disease. Catarrhal mastitis with primary inflammation of the 
interstitial tissues is often seen in females. In the later 
stages, there may be secondary acinar involvement, fibrosis 
and/ or parenchymatous atrophy. Arthritis with periarticular 
edema may be noted, particularly in the carpal joints. The 
synovial membranes may be hyperemic, and the joint fluid 
can be hemorrhagic or turbid. Serous or mucopurulent 
conjunctivitis, keratitis or, less frequently, corneal 
ulceration may also be present.  
Some organisms have also been associated with genital 
lesions including vulvovaginitis, cystic catarrhal metritis 
and/or salpingitis in females, and balanoposthitis or 
testicular degeneration in males.  
Morbidity and Mortality 
Contagious agalactia is mainly reported in milking sheep 
and goats. Animals are particularly susceptible at the 
beginning of lactation. When an organism is first introduced 
into a susceptible flock or herd, the morbidity rate is 
approximately 30-60%; in some cases, most of the 
susceptible animals become ill. The mortality rate varies and 
is often 20% or less. However, it may initially reach 40-70%, 
especially in young animals with septicemia. M. putrefaciens 
may be less virulent than M. mycoides mycoides LC or M. 
capricolum capricolum, but severe, highly fatal disease has 
been reported when M. putrefaciens and M. agalactiae 
occurred together in goats. In one outbreak caused by 
consurrent infection with these two organisms, 80% of the 
herd died or was euthanized due to severe debilitation. Once 
an organism has become established in the herd, infections 
tend to be subacute or chronic. 
Diagnosis 
Clinical 
Contagious agalactia should be suspected in a flock or 
herd with mastitis and decreased milk production, 
keratoconjunctivitis and arthritis, particularly when these 
signs develop near the time of parturition. Acute septicemia 
can also be seen, especially in young animals, and is more 
difficult to diagnose. 
Differential diagnosis 
Contagious agalactia must be distinguished from other 
causes of pneumonia, mastitis and/or arthritis including 
Manheimia haemolytica, Streptococcus spp., 
Staphylococcus spp., Escherichia coli, Klebsiella 
pneumoniae, caprine arthritis encephalitis virus, 
Erysipelothrix rhusiopathiae and other organisms.  
Laboratory tests 
Contagious agalactia can be diagnosed by isolating the 
causative organism. The Mycoplasma species that cause 
contagious agalactia can grow on most mycoplasma media, 
producing colonies within 3-4 days. Typical fried egg 
colonies are seen on solid media. Isolates can be identified 
with biochemical tests and serology. Serological tests used 
for identification include the growth inhibition (GIT), film 
inhibition (FIT), indirect fluorescent antibody (IFA)  and 
dot immunobinding tests. Polymerase chain reaction (PCR) 
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assays are increasingly used to identify isolates. Clone 
purification of colonies is often necessary before an isolate 
can be identified by GIT or FIT; definitive diagnosis using 
these tests takes at least two weeks. PCR, IFA and the dot 
immunobinding test do not require cloning, and can be done 
rapidly. 
PCR techniques can identify organisms directly in 
clinical samples including nasal, conjunctival and synovial 
exudates, milk, and tissue samples. Positive PCR results 
should be confirmed by isolation and identification of the 
organism, especially in areas where contagious agalactia is 
not usually found. Negative PCR results are not considered 
definitive. 
Serology can be useful as a herd test. Serological tests 
have been developed for most of the organisms that cause 
contagious agalactia, but assays for M. putrefaciens are not 
widely available. Complement fixation and enzyme–linked 
immunosorbent assays (ELISA) are the most commonly 
used tests. Commercial ELISAs have been developed for 
M. agalactiae, and ELISAs for other causative organisms 
may be available in individual laboratories. Immunoblotting 
and indirect hemagglutination may also be used. In areas 
that are free of contagious agalactia, a serological diagnosis 
should be confirmed by isolation of the organism.  
Samples to collect 
Before collecting or sending any samples from 
animals with a suspected foreign animal disease, the 
proper authorities should be contacted. Samples should 
only be sent under secure conditions and to authorized 
laboratories to prevent the spread of the disease. 
In live animals, the preferred samples for culture are 
nasal swabs and exudates, aspirated joint fluid from cases of 
arthritis, eye swabs from cases with ocular disease, and milk. 
Milk should be collected from animals with mastitis, or from 
healthy animals when clinical signs are common in young, 
nursing animals. Ear swabs may also contain organisms, but 
the concurrent presence of other Mycoplasma species can 
make isolation difficult. Mycoplasmas can be isolated from 
blood samples during acute disease. PCR can detect 
organisms in nasal, conjunctival and synovial exudates, milk, 
and tissue samples. 
The optimal samples at necropsy are the udder and its 
associated lymph nodes, joint fluid, pleural or pericardial 
fluid, and samples from lung lesions taken at the interface 
between diseased and healthy tissue. Some authorities also 
recommend blood, urine, liver, spleen and other organs. 
Samples for culture should be collected aseptically and 
placed in transport medium (e.g., heart infusion broth with 
20% serum, 10% yeast extract and benzylpenicillin). 
Samples should be kept cool and transported promptly to 
the laboratory on wet ice. If samples must be held for more 
than a few days, they may be frozen.  
For serology, serum should be collected from both 
clinically affected and asymptomatic animals. At least 10 
serum samples, preferably from acute and convalescent 
cases, are collected for complement fixation.  
Recommended actions if contagious 
agalactia is suspected 
Notification of authorities 
Contagious agalactia is reportable to the World 
Organization for Animal Health (OIE). Disease notification 
requirements for OIE member nations and import/export 
guidelines can be found in the OIE Terrestrial Animal 
Health Code [http://www.oie.int/international-standard-
setting/terrestrial-manual/access-online/]. Veterinarians 
who encounter a case of contagious agalactia should follow 
their national and/or local guidelines for disease reporting 
and diagnostic testing. 
Notification of authorities in the United States 
Contagious agalactia should be reported immediately 
to state or federal authorities.  
Federal: Area Veterinarians in Charge (AVIC): 
www.aphis.usda.gov/animal_health/area_offices/ 
State Veterinarians:   
www.usaha.org/Portals/6/StateAnimalHealthOfficials.pdf 
Control 
In areas that are free of contagious agalactia, infected 
herds are usually quarantined and euthanized. The premises 
should be cleaned and disinfected before restocking. 
Mycoplasmas can be inactivated by many disinfectants 
including sodium hypochlorite (30 ml of household bleach in 
1 gallon of water), 2% sodium hydroxide (pH 12.4), 1% 
formalin, cresol, sodium carbonate (4% anhydrous or 10% 
crystalline with 1% detergent), and ionic and nonionic 
detergents. Eradication has been accomplished in some areas 
by the euthanasia of infected and exposed flocks or herds. 
In endemic areas, good management and hygiene can 
reduce the transmission of contagious agalactia in a herd. The 
premises and equipment should be cleaned and disinfected 
regularly, and sick animals should be isolated. Milking 
animals should also be separated from young animals. 
Removal of the newborn from the dam, with feeding of 
pasteurized colostrum and milk, can be helpful. Regular 
testing of the flock or herd, with culling or isolation of 
infected animals, can also help prevent disease introduction 
and/or reduce its spread. ELISAs, culture and other tests have 
been useful in screening programs. 
Antibiotics can result in symptomatic improvement, 
but they may not be effective in chronic joint infections or 
keratoconjunctivitis. Treatment may not eliminate the 
infection from carriers. Vaccines may be available for some 
organisms in some areas. Inactivated vaccines generally 
provide short-term protection. Live vaccines can prevent 
symptoms, but do not prevent animals from becoming 
infected or shedding the organism. Vaccine organisms may 
also be shed in the milk.  
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Public Health 
There is no evidence that M. agalactiae is a threat to 
human health. 
Internet Resources 
The Merck Veterinary Manual 
http://www.merckvetmanual.com/mvm/index.jsp 




World Organization for Animal Health (OIE) 
http://www.oie.int 
OIE Manual of Diagnostic Tests and Vaccines for  
Terrestrial Animals  
http://www.oie.int/international-standard-
setting/terrestrial-manual/access-online/ 
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